At TAPI, we are committed to protecting the environment. Our R&D and production sites all comply with major international, regional and local environmental regulations, and our European plants comply with REACH (Registration, Evaluation and Authorization of Chemicals) legislation of the European community.
TAPI undertakes continuous efforts to reduce the emission of greenhouse pollutants including carbon dioxide (CO2), sulphur oxides (SOx), nitrogen oxides (NOx) and volatile organic compounds (VOCs).
We also pay special attention to the development, installation and maintenance of recycling and waste treatment processes. Significant investments are carried out at our sites to install modern equipment for wastewater and air treatment.
TAPI is a division of Teva Pharmaceutical Industries Ltd., the global generic pharmaceutical leader and one of the world’s top 15 pharmaceutical companies. Read
more about Teva’s ongoing commitment to the environment.